跳至主要内容
临床试验/NCT07280507
NCT07280507进行中(未招募)1 期

Comparative Evaluation of Microneedling With Injectable PRF and Hyaluronic Acid for Papilla Reconstruction: A Randomized Clinical Trial

King Abdulaziz University1 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2025年11月24日最近更新:
干预措施

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
7
试验地点
1
主要终点
Papillary height

研究概览

简要总结

This randomized split-mouth clinical trial aims to compare the clinical effectiveness of microneedling combined with injectable platelet-rich fibrin (i-PRF) versus hyaluronic acid (HA) gel injection in the reconstruction of Class I interdental papilla loss. The study hypothesizes that MN + i-PRF will yield greater papillary regeneration, offering a minimally invasive, biologically active alternative to traditional surgical approaches for soft-tissue esthetic rehabilitation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Plaque index <1
  • Gingival index <1
  • Class I papillary loss (Nordland and Tarnow classification)
  • Probing depth ≤4 mm at the test site
  • Inter-proximal bone crest distance ≤7 mm from the contact point.

排除标准

  • Pregnancy
  • Lactation
  • Uncontrolled systemic diseases (e.g., diabetes)
  • Anticoagulant therapy
  • Recent radiotherapy
  • Orthodontic treatment
  • Midline diastema
  • High frenum attachment
  • Class II/III papillary loss.

研究组 & 干预措施

HA

Experimental

Hyaluronic Acid Filler

干预措施: Hyaluronic Acid (HA) (Other)

iPRF

Active Comparator

干预措施: Injectable Platelet Rich Fibrin (Biological)

结局指标

主要结局

Papillary height

时间窗: Baseline, 6 weeks, and 12 weeks.

from the mucogingival junction to the papilla tip

Papillary width

时间窗: 12 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amal Jamjoom, BDS, MS.

Assistant Professor

King Abdulaziz University

研究点 (1)

Loading locations...

相似试验